Gulisa Turashvili

Gulisa Turashvili MD, PhD, FRCPC, FCAP
Assistant Professor
Anatomic Pathology
Department of Laboratory Medicine & Pathobiology
Gulisa Turashvili
Contact Info
T: (416) 586-4800 5931
F: (416) 586-8628
Sinai Health: Mount Sinai
600 University Ave.
Department of Pathology & Lab Med
Toronto, ON, M5G 1X5
Appointment Status Primary
Clinical Interests
Anatomic Pathology, Gynaecologic Pathology, Breast Pathology
Research Interests
Cancer, Molecular & Cell Biology

Dr. Turashvili obtained her MD degree at Tbilisi State Medical University (Georgia) and PhD degree (Pathology) at Palacky University (Czech Republic). After several years of research at University of British Columbia (Vancouver, BC), she completed residency training in Anatomical Pathology at Queen`s University (Kingston, ON), and two years of fellowship training in Breast and Gynecologic Pathology at Memorial Sloan Kettering Cancer Center (New York, NY). Dr. Turashvili joined the staff of Mount Sinai Hospital and the faculty of the University of Toronto in 2018.


Research Synopsis

My research interests include neoplastic and preneoplastic gynecologic diseases and breast cancer. The goal of my research is to better understand the biology of rare special subtypes of breast cancer as well as precursor lesions and malignant neoplasms of the uterine cervix and endometrium, and generate insights to inform the practice of Gynecologic and Breast Pathology.

Publications and Awards

View PubMed search of this faculty member's recent publications.

Recent Publications

Turashvili G, Lightbody ED, Tyryshkin K, SenGupta SK, Elliott BE, Madarnas Y, Ghaffari A, Day A, Nicol CJB. Novel prognostic and predictive microRNA targets for triple-negative breast cancer. FASEB J. 2018 May 29.

Turashvili G, Grisham RN, Chiang S, DeLair DF, Park KJ, Soslow RA, Murali R. BRAF(V)(600E) mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary. Histopathology. 2018;73(3):438-443. 

Turashvili G, Morency EG, Kracun M, DeLair DF, Chiang S, Soslow RA, Park KJ, Murali R. Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens. Int J Gynecol Pathol. 2018 May 10.

Mukherjee A, Russell R, Chin SF, Liu B, Rueda OM, Ali HR, Turashvili G, Mahler-Araujo B, Ellis IO, Aparicio S, Caldas C, Provenzano E. Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort. NPJ Breast Cancer. 2018;4:5.

Turashvili G, Gonzalez-Loperena M, Brogi E, Dickler M, Norton L, Morrow M, Wen HY. The 21-Gene Recurrence Score in Male Breast Cancer. Ann Surg Oncol. 2018;25(6):1530-1535.

Turashvili G, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up. BMC Cancer. 2018;18(1):42.

Turashvili G, Brogi E. Tumor Heterogeneity in Breast Cancer. Front Med (Lausanne). 2017;4:227.

Turashvili G, Chou JF, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2017;166(1):69-76.

Turashvili G, Brogi E, Morrow M, Hudis C, Dickler M, Norton L, Wen HY. The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis. Breast Cancer Res Treat. 2017;165(1):65-76.

Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C. The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479.

Turashvili G, Farmer P, Colgan T, Childs T. Human Papillomavirus-Related Ovarian Metastasis With Endocervical Adenocarcinoma: Report of 2 Cases and Review of Literature. J Low Genit Tract Dis. 2015;19(4):e60-3.

Koti M, Siu A, Clément I, Bidarimath M, Turashvili G, Edwards A, Rahimi K, Mes-Masson AM, Squire JA. A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer. Br J Cancer. 2015 Mar 31;112(7):1215-22.

Turashvili G, Childs T. Mucinous metaplasia of the endometrium: current concepts. Gynecol Oncol. 2015;136(2):389-93

Vollan HK, Rueda OM, Chin SF, Curtis C, Turashvili G, Shah S, Lingjærde OC, Yuan Y, Ng CK, Dunning MJ, Dicks E, Provenzano E, Sammut S, McKinney S, Ellis IO, Pinder S, Purushotham A, Murphy LC, Kristensen VN; METABRIC Group, Brenton JD, Pharoah PD, Børresen-Dale AL, Aparicio S, Caldas C. A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer. Mol Oncol. 2015;9(1):115-27.

Dvinge H, Git A, Gräf S, Salmon-Divon M, Curtis C, Sottoriva A, Zhao Y, Hirst M, Armisen J, Miska EA, Chin SF, Provenzano E, Turashvili G, Green A, Ellis I, Aparicio S, Caldas C. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature. 2013;497(7449):378-82.